Rituximab Treatment of Fibrillary Glomerulonephritis
- 31 December 2008
- journal article
- case report
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 52 (6), 1158-1162
- https://doi.org/10.1053/j.ajkd.2008.07.011
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- B lymphocytes and lupus nephritis: New insights into pathogenesis and targeted therapiesKidney International, 2008
- Rituximab treatment of idiopathic membranous nephropathyKidney International, 2008
- Titrating Rituximab to Circulating B Cells to Optimize Lymphocytolytic Therapy in Idiopathic Membranous NephropathyClinical Journal of the American Society of Nephrology, 2007
- Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroidsRheumatology, 2006
- Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down‐regulation of the T cell costimulatory molecule CD40 ligand: An open‐label trialArthritis & Rheumatism, 2005
- Fibrillary glomerulonephritis and immunotactoid glomerulopathyNephrology Dialysis Transplantation, 2004
- Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic featuresKidney International, 2003
- Rituximab for idiopathic membranous nephropathyThe Lancet, 2002
- Immunotactoid GlomerulopathyJournal of the American Society of Nephrology, 2002
- Clinical and pathologic features of fibrillary glomerulonephritisKidney International, 1992